Tag archives: Church & Dwight

Second Circuit may address apparent Apotex/Church & Dwight split

In our September 28, 2016 blog post, and subsequent Law360 Article, we reported that an internal Second-Circuit split had arisen regarding the deference owed to allegedly false and misleading pharmaceutical/medical device advertising where the FDA had considered and approved similar claims for labeling. The earlier decision involved in the split, Apotex, Inc. v. Acorda Therapeutics, Inc.  823 F.3d 51 (2d … Continue reading
LexBlog